Drugmaker GlaxoSmithKlin logs slumping annual profits
Profit after tax sank to just under £4.4-billion (R91.21-billion) last year, the GSK said in a statement on Wednesday
Glaxosmithkline
SA, UK spearhead R500-million fund for joint scientific research
The two countries have set up the Newton Fund to focus on areas such as food security, the environment, and disease prevention and control.
No image available
Motsoaledi launches free HPV vaccine for schoolgirls
Health Minister Aaron Motsoaledi has launched an HPV vaccine programme for grade four girls in all government schools.
HIV research on monkeys makes breakthrough
A single shot of antiretroviral drugs has protected lab monkeys from HIV for weeks, according to two US trials.
There’s a new HIV drug – but Africa will have to wait
A new drug, Tivicay, that could be vital in the struggle against HIV, might not be available to those who need it the most.
No image available
Drug resistant Chinese bird flu raises concern
The new bird flu strain that has killed 36 people has proved resistant to Tamiflu for the first time, a development scientists find "concerning".
Pharmaceutical industry targets Africa’s growing middle class
According to data, by 2016 pharmaceutical spending in Africa is expected to reach $30-billion – driven by the continent’s increasing economic wealth.
Cervical cancer can be prevented
Cervical cancer is caused by a very common virus, but it is easy to detect and there is a vaccination for it, writes Mia Malan
Exposed: Bitter pill of bad pharma
A new book detailing how profit-hungry pharmaceutical companies mislead medical practitioners and harm patients may be just what the doctor ordered.
Pharmaceutical giant regrets corporate misconduct
GlaxoSmithKline has been fined $3-billion after admitting to encouraging the prescription of unsuitable antidepressants to children.
No image available
Identifying South Africa’s silent killers
Diseases with little or no symptoms are silently killing South Africans.
Breast is best – for slim adults
Exclusively breastfed babies are less likely to become obese adults, research has shown.
No image available
Big Pharma backs deal to boost flu pandemic readiness
Virus samples will be shared globally in exchange for vaccines produced from them under a landmark deal to improve preparedness for a flu pandemic.
No image available
GlaxoSmithKline urged to pool its patents on HIV drugs
Leading UK and international organisations have written to Britain’s largest drug company urging it to pool its patents on HIV medicines.
No image available
Roche defends diet drug as FDA probes liver claim
There is no evidence of a link between weight loss drug Xenical and liver injury, drugmaker Roche said on Tuesday.
No image available
Bill Gates in new push against malaria
Bill Gates and thousands of babies are helping Africa prepare its largest medical experiment ever in the search for a new vaccine against malaria.
No image available
NatWest Three may plea bargain over Enron charges
Three British bankers whose extradition to the United States caused a political storm last year are on the brink of a plea agreement that could involve an admission of wrongdoing over an alleged -million fraud related to the collapse of Enron.
No image available
Malaria vaccine shows promise in infants
A malaria vaccine currently under development can be safely given to young infants and appears to offer strong protection against the disease, according to the results of a study conducted in Mozambique. The finding clears the way for final-stage testing of GlaxoSmithKline’s vaccine, known as Mosquirix.
